domenica 6 ottobre 2013

Grifols sales 2012 issue

Grifols sales 2012 issue


Grifols resumes payment of cash dividends and keeps its commitment to a pay-out ratio of 40% of net profit.
Blood firm Grifols sees 2006 sales up 22 pct.
In conjunction with the licensing agreement, xmltag.

grifols sales 2012 issue


Grifols has been working in the fields of transfusion, blood banking, protein therapeutics and laboratory analysis for more than 70 years.
Grifols SA to Acquire Novartis DiagnosticsInternational law firm Milbank, Tweed, Hadley McCloy represented Nomura, Morgan Stanley and Banco Bilbao Vizcaya Argentaria SA as lead arrangers for a senior unsecured bridge loan for Grifols S.


Spain-based Grifols to acquire Novartis blood transfusion diagnostics unit for USD 1.
Novartis blood transfusion diagnostics unit enables us to focus more sharply on our strategic businesses while providing Grifols with a platform for global expansion,” Novartis CEO Joseph Jimenez said in a statement.


The Glendale Academyhad 458 participants in on-site classes and issued nearly 200 certificates toindividuals who completed online classes, with a total of 9,191 traininghours.
Pulmaquin is a dual release formulation that is a mixture of Lipoquin with unencapsulated ciprofloxacin.
Grifols reported sales worth 2 billion euros ($2.


Some of the investigations relate to sales practices by Talecris Biotherapeutics.
The Chinese institution is one of China’s leading blood transfusion centres; it serves over 20 million people and receives more than 300,000 donations per year.
The story of the Catalan firm Grifols is inexorably linked to an ambitious world business view.
Grifols President and CEO Víctor Grifols said in a press release that this “is a step further into our vision to become a world leader also in the diagnostics field.

Nessun commento:

Posta un commento

Nota. Solo i membri di questo blog possono postare un commento.